Skip Navigation

Cardiovascular Research 1997 36(2):163-173; doi:10.1016/S0008-6363(97)00172-7
© 1997 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Conway, S. J
Right arrow Articles by Copp, A. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conway, S. J
Right arrow Articles by Copp, A. J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Development of a lethal congenital heart defect in the splotch (Pax3) mutant mouse

Simon J Conwaya,b,*, Deborah J Hendersonb, Margaret L Kirbya, Robert H Andersonc and Andrew J Coppb

aDevelopmental Biology Program, Institute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, GA 30912-2640, USA
bNeural Development Unit, Institute of Child Health, University of London, 30 Guilford Street, London WC1N 1EH, UK
cNational Heart and Lung Institute, Imperial College School of Medicine, University of London, London, UK

* Corresponding author. Tel.: +1 706 7218775; Fax: +1 706 7218685; E-mail: sconway@mail.mcg.edu

Objective: The splotch (Sp2H) mutation disrupts the Pax3 gene and is lethal in homozygotes. The aim of the present study was to investigate the cause of lethality. Methods and results: Using the splotch (Sp2H) mouse mutant, we demonstrated that approximately 60% of Sp2H homozygotes die in utero at 13.5–14.5 days of gestation. All these embryos have cardiac malformations involving partial or complete failure of septation of the outflow tract. Although the cause of death in utero is unknown, the dying embryos are edematous, their superior caval veins are over-expanded, and the fetal liver is enlarged and engorged with blood, all signs of cardiac failure. The remaining Sp2H homozygotes die around the time of birth, and these embryos have grossly normal hearts. All Sp2H homozygotes have neural tube defects, either spina bifida, exencephaly, or both. Although these defects clearly do not cause death in utero, they are very likely responsible for the perinatal death of homozygotes that survive to late gestation. There is no correlation between the presence or absence of a cardiac defect and the type of neural tube defect. On the other hand, there is a striking correlation between presence of a cardiac defect and reduction or absence of dorsal root ganglia, which are derivatives of the neural crest. Conclusions: In this paper, we show that the lethality has a biphasic pattern, and the data strongly suggests that mid-gestation lethality is due to cardiac defects and not the associated neural tube defects. This finding supports the idea that ‘conotruncal’ cardiac defects involving the ventricular outflow tracts develop as a result of failure of the ‘cardiac’ neural crest to colonise the developing heart in the mid-gestation embryo, and that the resulting heart defects are solely responsible for the observed mortality.

KEYWORDS Mouse mutant; Congenital heart disease; Neural tube defects; Pax; Splotch; Cardiac neural crest; Heart failure


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Circ Cardiovasc GenetHome page
E. Goldmuntz, S. Woyciechowski, D. Renstrom, P. J. Lupo, and L. E. Mitchell
Variants of Folate Metabolism Genes and the Risk of Conotruncal Cardiac Defects
Circ Cardiovasc Genet, December 1, 2008; 1(2): 126 - 132.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
C.-P. Chang, K. Stankunas, C. Shang, S.-C. Kao, K. Y. Twu, and M. L. Cleary
Pbx1 functions in distinct regulatory networks to pattern the great arteries and cardiac outflow tract
Development, November 1, 2008; 135(21): 3577 - 3586.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
D Obler, A L Juraszek, L B Smoot, and M R Natowicz
Double outlet right ventricle: aetiologies and associations
J. Med. Genet., August 1, 2008; 45(8): 481 - 497.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Ream, A. M. Ray, R. Chandra, and D. M. Chikaraishi
Early fetal hypoxia leads to growth restriction and myocardial thinning
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R583 - R595.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. Bajolle, S. Zaffran, R. G. Kelly, J. Hadchouel, D. Bonnet, N. A. Brown, and M. E. Buckingham
Rotation of the Myocardial Wall of the Outflow Tract Is Implicated in the Normal Positioning of the Great Arteries
Circ. Res., February 17, 2006; 98(3): 421 - 428.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
Y. Wang, E. Vachon, J. Zhang, V. Cherepanov, J. Kruger, J. Li, K. Saito, P. Shannon, N. Bottini, H. Huynh, et al.
Tyrosine phosphatase MEG2 modulates murine development and platelet and lymphocyte activation through secretory vesicle function
J. Exp. Med., December 5, 2005; 202(11): 1587 - 1597.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
P. R.J. Bois, K. Izeradjene, P. J. Houghton, J. L. Cleveland, J. A. Houghton, and G. C. Grosveld
FOXO1a acts as a selective tumor suppressor in alveolar rhabdomyosarcoma
J. Cell Biol., September 12, 2005; 170(6): 903 - 912.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. A. Nichols and T. L. Creazzo
L-type Ca2+ channel function in the avian embryonic heart after cardiac neural crest ablation
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1173 - H1178.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
T. L. Macatee, B. P. Hammond, B. R. Arenkiel, L. Francis, D. U. Frank, and A. M. Moon
Ablation of specific expression domains reveals discrete functions of ectoderm- and endoderm-derived FGF8 during cardiovascular and pharyngeal development
Development, December 22, 2003; 130(25): 6361 - 6374.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
S. J. Kwang, S. M. Brugger, A. Lazik, A. E. Merrill, L.-Y. Wu, Y.-H. Liu, M. Ishii, F. O. Sangiorgi, M. Rauchman, H. M. Sucov, et al.
Msx2 is an immediate downstream effector of Pax3 in the development of the murine cardiac neural crest
Development, March 3, 2003; 129(2): 527 - 538.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z. Yin, J. Haynie, X. Yang, B. Han, S. Kiatchoosakun, J. Restivo, S. Yuan, N. R. Prabhakar, K. Herrup, R. A. Conlon, et al.
The essential role of Cited2, a negative regulator for HIF-1alpha , in heart development and neurulation
PNAS, August 6, 2002; 99(16): 10488 - 10493.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
D. U. Frank, L. K. Fotheringham, J. A. Brewer, L. J. Muglia, M. Tristani-Firouzi, M. R. Capecchi, and A. M. Moon
An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome
Development, January 10, 2002; 129(19): 4591 - 4603.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. F. Machado, E. F. Zimmerman, D. N. Hovland Jr., R. Weiss, and M. D. Collins
Diabetic Embryopathy in C57BL/6J Mice: Altered Fetal Sex Ratio and Impact of the Splotch Allele
Diabetes, May 1, 2001; 50(5): 1193 - 1199.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Ausoni and S. Sartore
Cell Lineages and Tissue Boundaries in Cardiac Arterial and Venous Poles : Developmental Patterns, Animal Models, and Implications for Congenital Vascular Diseases
Arterioscler Thromb Vasc Biol, March 1, 2001; 21(3): 312 - 320.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. J. Anderson, G. D. Shelton, W. K. Cavenee, and K. C. Arden
Embryonic expression of the tumor-associated PAX3-FKHR fusion protein interferes with the developmental functions of Pax3
PNAS, February 13, 2001; 98(4): 1589 - 1594.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. J. Scambler
The 22q11 deletion syndromes
Hum. Mol. Genet., October 1, 2000; 9(16): 2421 - 2426.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. J.B. van den Hoff and A. F.M. Moorman
Cardiac neural crest: the holy grail of cardiac abnormalities?
Cardiovasc Res, August 1, 2000; 47(2): 212 - 216.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. J. Conway, J. Bundy, J. Chen, E. Dickman, R. Rogers, and B. M. Will
Decreased neural crest stem cell expansion is responsible for the conotruncal heart defects within the Splotch (Sp2H)/Pax3 mouse mutant
Cardiovasc Res, August 1, 2000; 47(2): 314 - 328.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
R. Eferl, M. Sibilia, F. Hilberg, A. Fuchsbichler, I. Kufferath, B. Guertl, R. Zenz, E. F. Wagner, and K. Zatloukal
Functions of c-Jun in Liver and Heart Development
J. Cell Biol., May 31, 1999; 145(5): 1049 - 1061.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
T. Clark, S. Conway, I. Scott, P. Labosky, G Winnier, J Bundy, B. Hogan, and D. Greenspan
The mammalian Tolloid-like 1 gene, Tll1, is necessary for normal septation and positioning of the heart
Development, January 6, 1999; 126(12): 2631 - 2642.
[Abstract] [PDF]


Home page
Circ. Res.Home page
D. J. Henderson, S. J. Conway, N. D. E. Greene, D. Gerrelli, J. N. Murdoch, R. H. Anderson, and A. J. Copp
Cardiovascular Defects Associated With Abnormalities in Midline Development in the Loop-tail Mouse Mutant
Circ. Res., July 6, 2001; 89(1): 6 - 12.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.